Global Anastrozole (CAS 120511-73-1) Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ920161 No. of Pages: 129 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Anastrozole (CAS 120511-73-1) market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Anastrozole (CAS 120511-73-1) market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Anastrozole (CAS 120511-73-1) in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Original Drug
Generic Drug
Market Snapshot, By Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Yangtze River Pharma
Wanma Pharma
United Pharma
Roid Fitness
Kocak Pharma
Huapont Pharma
Hisun Pharma
Gear Phoenix
Cipla
AstraZenca Pharma
The study objectives of this report are:
To study and analyze the global Anastrozole (CAS 120511-73-1) market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Anastrozole (CAS 120511-73-1) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Anastrozole (CAS 120511-73-1) manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anastrozole (CAS 120511-73-1) market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Anastrozole (CAS 120511-73-1) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Anastrozole (CAS 120511-73-1) are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Anastrozole (CAS 120511-73-1) Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Anastrozole (CAS 120511-73-1) Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Anastrozole (CAS 120511-73-1)
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Anastrozole (CAS 120511-73-1) Sales Channel and Distributors Analysis
3.3.1 Anastrozole (CAS 120511-73-1) Sales Channel
3.3.2 Anastrozole (CAS 120511-73-1) Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Hospital Pharmacies
3.4.2 Major Buyers in Retail Pharmacies
3.5 Anastrozole (CAS 120511-73-1) Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Anastrozole (CAS 120511-73-1) Type Introduction
4.1.1 Original Drug
4.1.2 Generic Drug
4.2 Global Anastrozole (CAS 120511-73-1) Sales by Type 2016-2021
4.3 Global Anastrozole (CAS 120511-73-1) Revenue by Type 2016-2021
4.4 Global Anastrozole (CAS 120511-73-1) Price by Type 2016-2021
5 Market Segment: by Application
5.1 Anastrozole (CAS 120511-73-1) Type Introduction
5.1.1 Hospital Pharmacies
5.1.2 Retail Pharmacies
5.1.3 Online Pharmacies
5.2 Global Anastrozole (CAS 120511-73-1) Sales by Application 2016-2021
5.3 Global Anastrozole (CAS 120511-73-1) Revenue by Application 2016-2021
5.4 Global Anastrozole (CAS 120511-73-1) Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Anastrozole (CAS 120511-73-1) Market by Region
6.1.1 Global Anastrozole (CAS 120511-73-1) Sales by Regions
6.1.2 Global Anastrozole (CAS 120511-73-1) Revenue by Regions
6.2 North America Anastrozole (CAS 120511-73-1) Market 2016-2021
6.3 Europe Anastrozole (CAS 120511-73-1) Market 2016-2021
6.4 Asia Pacific Anastrozole (CAS 120511-73-1) Market 2016-2021
6.5 South America Anastrozole (CAS 120511-73-1) Market 2016-2021
6.6 Middle East and Africa Anastrozole (CAS 120511-73-1) Market 2016-2021
7 North America
7.1 North America Anastrozole (CAS 120511-73-1) Market by Country 2016-2021
7.1.1 North America Anastrozole (CAS 120511-73-1) Sales by Country
7.1.2 North America Anastrozole (CAS 120511-73-1) Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Anastrozole (CAS 120511-73-1) Market by Country 2016-2021
8.1.1 Europe Anastrozole (CAS 120511-73-1) Sales by Country
8.1.2 Europe Anastrozole (CAS 120511-73-1) Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Anastrozole (CAS 120511-73-1) Market by Country 2016-2021
9.1.1 Asia Pacific Anastrozole (CAS 120511-73-1) Sales by Country
9.1.2 Asia Pacific Anastrozole (CAS 120511-73-1) Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Anastrozole (CAS 120511-73-1) Market by Country 2016-2021
10.1.1 South America Anastrozole (CAS 120511-73-1) Sales by Country
10.1.2 South America Anastrozole (CAS 120511-73-1) Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Anastrozole (CAS 120511-73-1) Market by Country 2016-2021
11.1.1 Middle East and Africa Anastrozole (CAS 120511-73-1) Sales by Country
11.1.2 Middle East and Africa Anastrozole (CAS 120511-73-1) Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Yangtze River Pharma
12.1.1 Yangtze River Pharma
Company Information
12.1.2 Yangtze River Pharma
Anastrozole (CAS 120511-73-1) Product Portfolio, Specification and Application
12.1.3 Yangtze River Pharma
Anastrozole (CAS 120511-73-1) Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Yangtze River Pharma
Key Development
12.2 Wanma Pharma
12.2.1 Wanma Pharma
Company Information
12.2.2 Wanma Pharma
Anastrozole (CAS 120511-73-1) Product Portfolio, Specification and Application
12.2.3 Wanma Pharma
Anastrozole (CAS 120511-73-1) Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Wanma Pharma
Key Development
12.3 United Pharma
12.3.1 United Pharma
Company Information
12.3.2 United Pharma
Anastrozole (CAS 120511-73-1) Product Portfolio, Specification and Application
12.3.3 United Pharma
Anastrozole (CAS 120511-73-1) Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 United Pharma
Key Development
12.4 Roid Fitness
12.4.1 Roid Fitness
Company Information
12.4.2 Roid Fitness
Anastrozole (CAS 120511-73-1) Product Portfolio, Specification and Application
12.4.3 Roid Fitness
Anastrozole (CAS 120511-73-1) Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Roid Fitness
Key Development
12.5 Kocak Pharma
12.5.1 Kocak Pharma
Company Information
12.5.2 Kocak Pharma
Anastrozole (CAS 120511-73-1) Product Portfolio, Specification and Application
12.5.3 Kocak Pharma
Anastrozole (CAS 120511-73-1) Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Kocak Pharma
Key Development
12.6 Huapont Pharma
12.6.1 Huapont Pharma
Company Information
12.6.2 Huapont Pharma
Anastrozole (CAS 120511-73-1) Product Portfolio, Specification and Application
12.6.3 Huapont Pharma
Anastrozole (CAS 120511-73-1) Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Huapont Pharma
Key Development
12.7 Hisun Pharma
12.7.1 Hisun Pharma
Company Information
12.7.2 Hisun Pharma
Anastrozole (CAS 120511-73-1) Product Portfolio, Specification and Application
12.7.3 Hisun Pharma
Anastrozole (CAS 120511-73-1) Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Huapont Pharma
Key Development
12.9 Cipla
12.9.1 Cipla
Company Information
12.9.2 Cipla
Anastrozole (CAS 120511-73-1) Product Portfolio, Specification and Application
12.9.3 Cipla
Anastrozole (CAS 120511-73-1) Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Cipla
Key Development
12.8 Gear Phoenix
12.8.1 Gear Phoenix
Company Information
12.8.2 Gear Phoenix
Anastrozole (CAS 120511-73-1) Product Portfolio, Specification and Application
12.8.3 Gear Phoenix
Anastrozole (CAS 120511-73-1) Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Gear Phoenix
Key Development
13 Global Anastrozole (CAS 120511-73-1) Market Forecast by Region by Type and by Application
13.1 Global Anastrozole (CAS 120511-73-1) Sales, Revenue Forecast 2022-2027
13.2 Global Anastrozole (CAS 120511-73-1) Forecast by Regions
13.2.1 Global Anastrozole (CAS 120511-73-1) Sales Forecast by Region 2022-2027
13.2.2 Global Anastrozole (CAS 120511-73-1) Revenue Forecast by Region 2022-2027
13.3 Global Anastrozole (CAS 120511-73-1) Forecast by Type
13.3.1 Global Anastrozole (CAS 120511-73-1) Sales Forecast by Type 2022-2027
13.3.2 Global Anastrozole (CAS 120511-73-1) Revenue Forecast by Type 2022-2027
13.3.3 Global Anastrozole (CAS 120511-73-1) Price Forecast by Type 2022-2027
13.4 Global Anastrozole (CAS 120511-73-1) Forecast by Application
13.4.1 Global Anastrozole (CAS 120511-73-1) Sales Forecast by Application 2022-2027
13.4.2 Global Anastrozole (CAS 120511-73-1) Revenue Forecast by Application 2022-2027
13.4.3 Global Anastrozole (CAS 120511-73-1) Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com